| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Acute myeloid leukemia 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] RARA |
D06543 |
Vitamin A |
[4] 13, 49, 53, 90 |
| 2 | Adrenergic signaling in cardiomyocytes 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| 3 | AGE-RAGE signaling pathway in diabetic complications 2 genes, 1 drug (DrugBank), 2 diseases shown |
[2] VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| 4 | Alanine, aspartate and glutamate metabolism 4 genes, 1 drug (DrugBank), 14 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 5 | Alcoholism 3 genes, 2 drugs (DrugBank), 8 diseases shown |
[1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
| [2] DRD1, DRD2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
| 6 | Aldosterone synthesis and secretion 7 genes, 2 drugs (DrugBank), 14 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| [3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 7 | Alzheimer disease 9 genes, 2 drugs (DrugBank), 44 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 8 | Amphetamine addiction 9 genes, 4 drugs (DrugBank), 50 diseases shown |
[2] CACNA1C, CACNA1D |
D01908 |
Nilvadipine |
[1] 90 |
| [1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
| [1] DRD1 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 9 | Amyotrophic lateral sclerosis (ALS) 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 10 | Apoptosis - multiple species 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] NGFR |
D11028 |
Cenegermin |
[1] 90 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| 12 | Axon guidance 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 13 | B cell receptor signaling pathway 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 14 | beta-Alanine metabolism 3 genes, 1 drug (DrugBank), 14 diseases shown |
[3] ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 15 | Bile secretion 1 gene, 2 drugs (DrugBank), 6 diseases shown |
[1] CA2 |
D00218 |
Acetazolamide |
[6] 13, 90, 115, 155, 225, 230 |
| D01196 |
| D00653 |
Dorzolamide |
[1] 90 |
| D07871 |
| 16 | Bladder cancer 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| 17 | Butanoate metabolism 4 genes, 1 drug (DrugBank), 14 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 18 | C-type lectin receptor signaling pathway 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 19 | Calcium signaling pathway 15 genes, 5 drugs (DrugBank), 58 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| [3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [2] DRD1, DRD5 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| [1] PTGFR |
D08661 |
Unoprostone |
[1] 90 |
| 20 | cAMP signaling pathway 7 genes, 2 drugs (DrugBank), 7 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| [3] DRD1, DRD2, DRD5 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
| 21 | Carbohydrate digestion and absorption 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] CACNA1D |
D01908 |
Nilvadipine |
[1] 90 |
| 22 | Cardiac muscle contraction 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| 23 | Cellular senescence 6 genes, 2 drugs (DrugBank), 44 diseases shown |
[1] CACNA1D |
D01908 |
Nilvadipine |
[1] 90 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 24 | cGMP-PKG signaling pathway 12 genes, 3 drugs (DrugBank), 44 diseases shown |
[3] ADRA2A, ADRA2B, ADRA2C |
D02076 |
Brimonidine |
[1] 90 |
| D07540 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 25 | Chagas disease (American trypanosomiasis) 2 genes, 1 drug (DrugBank), 7 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| 26 | Cholinergic synapse 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| 27 | Circadian entrainment 7 genes, 3 drugs (DrugBank), 21 diseases shown |
[2] CACNA1C, CACNA1D |
D01908 |
Nilvadipine |
[1] 90 |
| [3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [2] MTNR1A, MTNR1B |
D08170 |
Melatonin |
[8] 6, 13, 46, 49, 90, 97, 144, 202 |
| 28 | Cocaine addiction 3 genes, 2 drugs (DrugBank), 8 diseases shown |
[1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
| [2] DRD1, DRD2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
| 29 | Collecting duct acid secretion 1 gene, 2 drugs (DrugBank), 6 diseases shown |
[1] CA2 |
D00218 |
Acetazolamide |
[6] 13, 90, 115, 155, 225, 230 |
| D01196 |
| D00653 |
Dorzolamide |
[1] 90 |
| D07871 |
| 30 | Cortisol synthesis and secretion 7 genes, 2 drugs (DrugBank), 14 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| [3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 31 | Cushing syndrome 7 genes, 2 drugs (DrugBank), 14 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| [3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 32 | Cytokine-cytokine receptor interaction 3 genes, 2 drugs (DrugBank), 7 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| [1] NGFR |
D11028 |
Cenegermin |
[1] 90 |
| 33 | Dilated cardiomyopathy (DCM) 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| 34 | Dopaminergic synapse 11 genes, 4 drugs (DrugBank), 50 diseases shown |
[2] CACNA1C, CACNA1D |
D01908 |
Nilvadipine |
[1] 90 |
| [1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
| [5] DRD1, DRD2, DRD3, DRD4, DRD5 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
| [3] PPP3CA, PPP3CB, PPP3CC |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 35 | EGFR tyrosine kinase inhibitor resistance 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| 36 | Estrogen signaling pathway 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] RARA |
D06543 |
Vitamin A |
[4] 13, 49, 53, 90 |
| 37 | Fluid shear stress and atherosclerosis 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| 38 | Focal adhesion 3 genes, 1 drug (DrugBank), 2 diseases shown |
[3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| 39 | GABAergic synapse 7 genes, 2 drugs (DrugBank), 14 diseases shown |
[3] ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| 40 | Gap junction 2 genes, 1 drug (DrugBank), 7 diseases shown |
[2] DRD1, DRD2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
| 41 | Gastric acid secretion 1 gene, 2 drugs (DrugBank), 6 diseases shown |
[1] CA2 |
D00218 |
Acetazolamide |
[6] 13, 90, 115, 155, 225, 230 |
| D01196 |
| D00653 |
Dorzolamide |
[1] 90 |
| D07871 |
| 42 | Gastric cancer 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] RARB |
D06543 |
Vitamin A |
[4] 13, 49, 53, 90 |
| 43 | Glucagon signaling pathway 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 44 | Glutamatergic synapse 7 genes, 2 drugs (DrugBank), 44 diseases shown |
[2] CACNA1C, CACNA1D |
D01908 |
Nilvadipine |
[1] 90 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 45 | GnRH secretion 7 genes, 2 drugs (DrugBank), 14 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| [3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 46 | GnRH signaling pathway 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| 47 | Growth hormone synthesis, secretion and action 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| 48 | Herpes simplex virus 1 infection 2 genes, 1 drug (DrugBank), 7 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| 49 | HIF-1 signaling pathway 3 genes, 2 drugs (DrugBank), 8 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| [1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| 50 | Human cytomegalovirus infection 6 genes, 2 drugs (DrugBank), 45 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| [1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| 51 | Human immunodeficiency virus 1 infection 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 52 | Human papillomavirus infection 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| 53 | Human T-cell leukemia virus 1 infection 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 54 | Hypertrophic cardiomyopathy (HCM) 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| 55 | Inflammatory bowel disease (IBD) 2 genes, 1 drug (DrugBank), 7 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| 56 | Influenza A 2 genes, 1 drug (DrugBank), 7 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| 57 | Insulin secretion 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| 58 | JAK-STAT signaling pathway 2 genes, 1 drug (DrugBank), 7 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| 59 | Kaposi sarcoma-associated herpesvirus infection 7 genes, 3 drugs (DrugBank), 48 diseases shown |
[1] IFNGR1 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| [1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| 60 | Leishmaniasis 2 genes, 1 drug (DrugBank), 7 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| 61 | Long-term potentiation 6 genes, 2 drugs (DrugBank), 44 diseases shown |
[1] CACNA1C |
D01908 |
Nilvadipine |
[1] 90 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 62 | MAPK signaling pathway 16 genes, 5 drugs (DrugBank), 55 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| [3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [1] NGFR |
D11028 |
Cenegermin |
[1] 90 |
| [3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 63 | Metabolic pathways 18 genes, 4 drugs (DrugBank), 24 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [13] CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 |
D00218 |
Acetazolamide |
[6] 13, 90, 115, 155, 225, 230 |
| D01196 |
| D00653 |
Dorzolamide |
[1] 90 |
| D07871 |
| [1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
| 64 | MicroRNAs in cancer 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| 65 | Morphine addiction 1 gene, 1 drug (DrugBank), 7 diseases shown |
[1] DRD1 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
| 66 | Natural killer cell mediated cytotoxicity 7 genes, 2 drugs (DrugBank), 47 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 67 | Necroptosis 2 genes, 1 drug (DrugBank), 7 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| 68 | Neuroactive ligand-receptor interaction 12 genes, 8 drugs (DrugBank), 40 diseases shown |
[3] ADRA2A, ADRA2B, ADRA2C |
D02076 |
Brimonidine |
[1] 90 |
| D07540 |
| [5] DRD1, DRD2, DRD3, DRD4, DRD5 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
| [2] MTNR1A, MTNR1B |
D08170 |
Melatonin |
[8] 6, 13, 46, 49, 90, 97, 144, 202 |
| [1] NR3C1 |
D00244 |
Betamethasone |
[6] 2, 46, 65, 90, 96, 235 |
| D00972 |
| D01357 |
| D01402 |
| D01637 |
| D02032 |
| D02286 |
| D00292 |
Dexamethasone |
[20] 13, 16, 28, 35, 46, 53, 63, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 222, 296, 299 |
| D00975 |
| D01510 |
| D01615 |
| D01632 |
| D01948 |
| D02174 |
| D02591 |
| D02592 |
| D01825 |
Fluocinolone acetonide |
[1] 90 |
| D00385 |
Triamcinolone |
[18] 6, 10, 13, 35, 40, 41, 42, 43, 44, 45, 46, 56, 70, 90, 96, 97, 226, 298 |
| D00983 |
| D00984 |
| D00985 |
| D06216 |
| [1] PTGFR |
D08661 |
Unoprostone |
[1] 90 |
| 69 | Neurotrophin signaling pathway 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] NGFR |
D11028 |
Cenegermin |
[1] 90 |
| 70 | Nitrogen metabolism 13 genes, 2 drugs (DrugBank), 6 diseases shown |
[13] CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 |
D00218 |
Acetazolamide |
[6] 13, 90, 115, 155, 225, 230 |
| D01196 |
| D00653 |
Dorzolamide |
[1] 90 |
| D07871 |
| 71 | Non-small cell lung cancer 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] RARB |
D06543 |
Vitamin A |
[4] 13, 49, 53, 90 |
| 72 | Oocyte meiosis 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 73 | Osteoclast differentiation 7 genes, 2 drugs (DrugBank), 47 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 74 | Oxytocin signaling pathway 9 genes, 2 drugs (DrugBank), 44 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 75 | Pancreatic cancer 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| 76 | Pancreatic secretion 1 gene, 2 drugs (DrugBank), 6 diseases shown |
[1] CA2 |
D00218 |
Acetazolamide |
[6] 13, 90, 115, 155, 225, 230 |
| D01196 |
| D00653 |
Dorzolamide |
[1] 90 |
| D07871 |
| 77 | Parkinson disease 2 genes, 1 drug (DrugBank), 7 diseases shown |
[2] DRD1, DRD2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
| 78 | Pathways in cancer 7 genes, 3 drugs (DrugBank), 11 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| [3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| [2] RARA, RARB |
D06543 |
Vitamin A |
[4] 13, 49, 53, 90 |
| 79 | PD-L1 expression and PD-1 checkpoint pathway in cancer 7 genes, 2 drugs (DrugBank), 47 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 80 | Phenylalanine metabolism 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
| 81 | Phospholipase D signaling pathway 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] PTGFR |
D08661 |
Unoprostone |
[1] 90 |
| 82 | PI3K-Akt signaling pathway 4 genes, 2 drugs (DrugBank), 2 diseases shown |
[1] NGFR |
D11028 |
Cenegermin |
[1] 90 |
| [3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| 83 | Propanoate metabolism 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] ABAT |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 84 | Proteoglycans in cancer 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| 85 | Proximal tubule bicarbonate reclamation 2 genes, 2 drugs (DrugBank), 6 diseases shown |
[2] CA2, CA4 |
D00218 |
Acetazolamide |
[6] 13, 90, 115, 155, 225, 230 |
| D01196 |
| D00653 |
Dorzolamide |
[1] 90 |
| D07871 |
| 86 | Rap1 signaling pathway 5 genes, 3 drugs (DrugBank), 8 diseases shown |
[1] DRD2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
| [1] NGFR |
D11028 |
Cenegermin |
[1] 90 |
| [3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| 87 | Ras signaling pathway 4 genes, 2 drugs (DrugBank), 2 diseases shown |
[1] NGFR |
D11028 |
Cenegermin |
[1] 90 |
| [3] PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| 88 | Relaxin signaling pathway 2 genes, 1 drug (DrugBank), 2 diseases shown |
[2] VEGFA, VEGFB |
D09574 |
Aflibercept |
[2] 90, 166 |
| 89 | Renal cell carcinoma 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| 90 | Renin secretion 9 genes, 2 drugs (DrugBank), 44 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 91 | Retrograde endocannabinoid signaling 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| 92 | Rheumatoid arthritis 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| 93 | Salmonella infection 2 genes, 1 drug (DrugBank), 7 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| 94 | Serotonergic synapse 5 genes, 2 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| [1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
| 95 | Small cell lung cancer 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] RARB |
D06543 |
Vitamin A |
[4] 13, 49, 53, 90 |
| 96 | T cell receptor signaling pathway 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 97 | Taste transduction 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] CACNA1C |
D01908 |
Nilvadipine |
[1] 90 |
| 98 | Taurine and hypotaurine metabolism 2 genes, 1 drug (DrugBank), 14 diseases shown |
[2] GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 99 | Th1 and Th2 cell differentiation 7 genes, 2 drugs (DrugBank), 47 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 100 | Th17 cell differentiation 8 genes, 3 drugs (DrugBank), 48 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| [1] RARA |
D06543 |
Vitamin A |
[4] 13, 49, 53, 90 |
| 101 | Tight junction 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] CACNA1D |
D01908 |
Nilvadipine |
[1] 90 |
| 102 | Toxoplasmosis 2 genes, 1 drug (DrugBank), 7 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| 103 | Transcriptional misregulation in cancer 2 genes, 2 drugs (DrugBank), 4 diseases shown |
[1] NGFR |
D11028 |
Cenegermin |
[1] 90 |
| [1] RARA |
D06543 |
Vitamin A |
[4] 13, 49, 53, 90 |
| 104 | Tryptophan metabolism 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
| 105 | Tuberculosis 7 genes, 2 drugs (DrugBank), 47 diseases shown |
[2] IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
[7] 65, 85, 90, 228, 299, 301, 326 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 106 | Type I diabetes mellitus 2 genes, 1 drug (DrugBank), 14 diseases shown |
[2] GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 107 | Type II diabetes mellitus 3 genes, 2 drugs (DrugBank), 14 diseases shown |
[2] CACNA1C, CACNA1D |
D01908 |
Nilvadipine |
[1] 90 |
| [1] CACNA1G |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 108 | Tyrosine metabolism 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
| 109 | Valine, leucine and isoleucine degradation 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] ABAT |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 110 | Vascular smooth muscle contraction 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01908 |
Nilvadipine |
[1] 90 |
| 111 | VEGF signaling pathway 6 genes, 2 drugs (DrugBank), 45 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| [1] VEGFA |
D09574 |
Aflibercept |
[2] 90, 166 |
| 112 | Wnt signaling pathway 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |